Bayesian deep neural networks for low-cost neurophysiological markers of Alzheimer's disease severity
원문 초록
As societies around the world are ageing, the number of Alzheimer's disease (AD) patients is rapidly increasing. To date, no low-cost, non-invasive biomarkers have been established to advance the objectivization of AD diagnosis and progression assessment. Here, we utilize Bayesian neural networks to develop a multivariate predictor for AD severity using a wide range of quantitative EEG (QEEG) markers. The Bayesian treatment of neural networks both automatically controls model complexity and provides a predictive distribution over the target function, giving uncertainty bounds for our regression task. It is therefore well suited to clinical neuroscience, where data sets are typically sparse and practitioners require a precise assessment of the predictive uncertainty. We use data of one of the largest prospective AD EEG trials ever conducted to demonstrate the potential of Bayesian deep learning in this domain, while comparing two distinct Bayesian neural network approaches, i.e., Monte Carlo dropout and Hamiltonian Monte Carlo.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
Dataset combining EEG, eye-tracking, and high-speed video for ocular activity analysis across BCI paradigms
A Statistical Approach for Synthetic EEG Data Generation
Decoding Covert Speech from EEG Using a Functional Areas Spatio-Temporal Transformer
EEG-CLIP : Learning EEG representations from natural language descriptions
Spatial Distillation based Distribution Alignment (SDDA) for Cross-Headset EEG Classification
Toward Foundational Model for Sleep Analysis Using a Multimodal Hybrid Self-Supervised Learning Framework
토론
이 논문과 연결된 포럼 글이 아직 없습니다.